Across
- 2. (C) Metformin _______ gluconeogenesis.
- 5. (S) There are currently _____ main manufacturers of CGMs.
- 6. (S) Medicare will cover CGMs for diabetic patients that are _______-dependent
- 9. (S) _______ patients had 21% lower odds of receiving a CGM prescription than White patients.
Down
- 1. (C) Metformin decreases glucose output from the _____.
- 3. (S) On average CGM costs 1,200 - 3,600 a year without ________.
- 4. (C) ______ should be avoided with metformin use.
- 7. (C) ____ is a common side effect of metformin.
- 8. (S) ____ patients had 38% lower odds of receiving a CGM prescription than White patients.
